80
China Biotech Services Holdings Limited
8037.HK · HKSE
$0.51 -3.81% (-$0.02)
1M -17.21%
Market Cap $512.3M
P/E Ratio -
Div. Yield -
ROE 31.06%
Analiza
Raport AI o biznesie, finansach, wycenie, sentymencie, wiadomościach i ryzykach - napisany w kilka minut.
Piotroski F-Score Weak
2/9Valuation
43 /100
Fair P/B 2.68x
P/S 6.97x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 31.77%
Rev. growth 65.89%
FCF growth N/A
Profitability
1 /100
Weak Op. margin 103.25%
Gross margin 10.51%
FCF margin 267.47%
Quality
1 /100
Poor ROA 9.79%
ROIC 12.70%
Asset turnover 0.10x
Debt
8 /100
High Int. coverage -3.90x
Debt/Equity 2.06x
Current ratio 0.23x
Stability
13 /100
Unstable EPS volatility 107.66%
Beta -0.67x
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o 8037.HK
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Xiaolin Liu
Employees
166
Headquarters
Hong Kong